Concepts (232)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Balloon Occlusion | 21 | 2020 | 38 | 3.770 |
Why?
|
| Resuscitation | 22 | 2020 | 69 | 3.090 |
Why?
|
| Hemorrhage | 10 | 2020 | 109 | 1.760 |
Why?
|
| Shock, Hemorrhagic | 16 | 2020 | 30 | 1.710 |
Why?
|
| Aorta | 17 | 2020 | 139 | 1.540 |
Why?
|
| Wounds and Injuries | 6 | 2020 | 248 | 1.390 |
Why?
|
| Appendicitis | 4 | 2013 | 15 | 1.240 |
Why?
|
| Appendectomy | 4 | 2013 | 19 | 1.170 |
Why?
|
| Blood Transfusion | 3 | 2018 | 76 | 1.070 |
Why?
|
| Liver | 5 | 2020 | 513 | 1.060 |
Why?
|
| Swine | 19 | 2020 | 233 | 1.020 |
Why?
|
| Specialties, Surgical | 2 | 2018 | 27 | 0.990 |
Why?
|
| Military Medicine | 3 | 2018 | 26 | 0.990 |
Why?
|
| Disease Models, Animal | 18 | 2020 | 1129 | 0.980 |
Why?
|
| Afghan Campaign 2001- | 4 | 2018 | 14 | 0.790 |
Why?
|
| Child | 14 | 2019 | 2615 | 0.720 |
Why?
|
| Aorta, Thoracic | 5 | 2019 | 87 | 0.680 |
Why?
|
| Injury Severity Score | 2 | 2018 | 113 | 0.640 |
Why?
|
| Hospitals, Military | 3 | 2017 | 12 | 0.610 |
Why?
|
| Child, Preschool | 10 | 2019 | 1355 | 0.600 |
Why?
|
| Hemodynamics | 9 | 2018 | 168 | 0.600 |
Why?
|
| Critical Care | 5 | 2019 | 113 | 0.590 |
Why?
|
| Reperfusion Injury | 5 | 2019 | 60 | 0.590 |
Why?
|
| Animals | 24 | 2020 | 8579 | 0.570 |
Why?
|
| Hospitals, Pediatric | 3 | 2013 | 48 | 0.570 |
Why?
|
| Blood Pressure | 6 | 2019 | 902 | 0.550 |
Why?
|
| Blood Vessel Prosthesis Implantation | 3 | 2017 | 65 | 0.540 |
Why?
|
| Hemoperitoneum | 1 | 2017 | 4 | 0.530 |
Why?
|
| Plasma | 1 | 2017 | 15 | 0.530 |
Why?
|
| Platelet Transfusion | 1 | 2017 | 17 | 0.530 |
Why?
|
| Burns | 4 | 2014 | 103 | 0.530 |
Why?
|
| Fellowships and Scholarships | 1 | 2018 | 56 | 0.530 |
Why?
|
| Tomography, X-Ray Computed | 6 | 2017 | 988 | 0.520 |
Why?
|
| Erythrocyte Transfusion | 1 | 2017 | 35 | 0.520 |
Why?
|
| Retrospective Studies | 14 | 2020 | 3825 | 0.490 |
Why?
|
| Adolescent | 12 | 2018 | 3807 | 0.490 |
Why?
|
| Female | 28 | 2020 | 21553 | 0.480 |
Why?
|
| Male | 27 | 2020 | 20763 | 0.480 |
Why?
|
| Abdominal Injuries | 1 | 2016 | 32 | 0.470 |
Why?
|
| Blood Vessel Prosthesis | 3 | 2017 | 87 | 0.440 |
Why?
|
| Pediatrics | 2 | 2015 | 167 | 0.430 |
Why?
|
| Hypertension | 2 | 2019 | 1025 | 0.420 |
Why?
|
| Direct Service Costs | 1 | 2013 | 2 | 0.410 |
Why?
|
| Plasma Exchange | 2 | 2013 | 14 | 0.400 |
Why?
|
| Stents | 3 | 2020 | 167 | 0.380 |
Why?
|
| Humans | 27 | 2020 | 34594 | 0.370 |
Why?
|
| Fundoplication | 1 | 2012 | 7 | 0.360 |
Why?
|
| Vomiting | 1 | 2012 | 23 | 0.360 |
Why?
|
| Gastroplasty | 1 | 2012 | 11 | 0.360 |
Why?
|
| Gastroesophageal Reflux | 1 | 2012 | 24 | 0.350 |
Why?
|
| Laparoscopy | 1 | 2013 | 194 | 0.350 |
Why?
|
| Cholelithiasis | 1 | 2011 | 10 | 0.340 |
Why?
|
| Healthcare Disparities | 1 | 2013 | 184 | 0.340 |
Why?
|
| Registries | 3 | 2018 | 328 | 0.340 |
Why?
|
| Infant | 6 | 2019 | 1123 | 0.330 |
Why?
|
| Cholecystectomy, Laparoscopic | 1 | 2011 | 22 | 0.330 |
Why?
|
| Ethnic Groups | 1 | 2013 | 483 | 0.330 |
Why?
|
| Endosonography | 1 | 2011 | 55 | 0.330 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2011 | 62 | 0.330 |
Why?
|
| Bioprosthesis | 1 | 2011 | 62 | 0.320 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2011 | 95 | 0.320 |
Why?
|
| Mediastinitis | 1 | 2009 | 7 | 0.300 |
Why?
|
| Branchial Region | 1 | 2009 | 4 | 0.300 |
Why?
|
| Empyema, Pleural | 1 | 2009 | 7 | 0.300 |
Why?
|
| Shock | 1 | 2009 | 34 | 0.290 |
Why?
|
| Referral and Consultation | 5 | 2014 | 149 | 0.290 |
Why?
|
| Tissue Engineering | 2 | 2012 | 700 | 0.280 |
Why?
|
| Wounds, Gunshot | 2 | 2020 | 35 | 0.280 |
Why?
|
| Reperfusion | 4 | 2020 | 21 | 0.270 |
Why?
|
| Infant, Newborn | 4 | 2018 | 730 | 0.240 |
Why?
|
| Treatment Outcome | 9 | 2020 | 3623 | 0.220 |
Why?
|
| Length of Stay | 3 | 2019 | 335 | 0.220 |
Why?
|
| Hospital Mortality | 2 | 2017 | 207 | 0.220 |
Why?
|
| Postoperative Complications | 3 | 2015 | 850 | 0.210 |
Why?
|
| Follow-Up Studies | 3 | 2015 | 2367 | 0.200 |
Why?
|
| Time Factors | 5 | 2020 | 2353 | 0.190 |
Why?
|
| Burn Units | 3 | 2014 | 28 | 0.190 |
Why?
|
| Random Allocation | 3 | 2017 | 257 | 0.180 |
Why?
|
| United States | 3 | 2015 | 4283 | 0.180 |
Why?
|
| Preoperative Care | 2 | 2012 | 129 | 0.170 |
Why?
|
| Hemostatic Techniques | 2 | 2018 | 7 | 0.170 |
Why?
|
| Multiple Trauma | 1 | 2020 | 42 | 0.160 |
Why?
|
| Bile Ducts | 1 | 2020 | 20 | 0.160 |
Why?
|
| Endothelial Cells | 2 | 2012 | 204 | 0.160 |
Why?
|
| Endocrine System | 1 | 2019 | 1 | 0.150 |
Why?
|
| Afghanistan | 2 | 2016 | 6 | 0.150 |
Why?
|
| Myocardial Ischemia | 1 | 2019 | 114 | 0.140 |
Why?
|
| Cold Temperature | 1 | 2018 | 61 | 0.140 |
Why?
|
| Vascular Patency | 3 | 2017 | 71 | 0.140 |
Why?
|
| Prosthesis Design | 3 | 2017 | 116 | 0.140 |
Why?
|
| Polytetrafluoroethylene | 1 | 2017 | 16 | 0.130 |
Why?
|
| Lower Extremity | 1 | 2018 | 106 | 0.130 |
Why?
|
| Forecasting | 1 | 2018 | 153 | 0.130 |
Why?
|
| Respiration, Artificial | 2 | 2019 | 105 | 0.130 |
Why?
|
| Iliac Artery | 1 | 2017 | 55 | 0.130 |
Why?
|
| Feasibility Studies | 2 | 2015 | 323 | 0.130 |
Why?
|
| Cholangiography | 2 | 2020 | 12 | 0.130 |
Why?
|
| Traumatology | 1 | 2016 | 9 | 0.120 |
Why?
|
| Cause of Death | 1 | 2017 | 245 | 0.120 |
Why?
|
| Aneurysm, Ruptured | 1 | 2016 | 33 | 0.120 |
Why?
|
| Risk Assessment | 2 | 2012 | 1508 | 0.120 |
Why?
|
| Chest Tubes | 1 | 2015 | 5 | 0.120 |
Why?
|
| Hemothorax | 1 | 2015 | 4 | 0.120 |
Why?
|
| Altruism | 1 | 2015 | 6 | 0.120 |
Why?
|
| Neurosurgical Procedures | 2 | 2019 | 101 | 0.120 |
Why?
|
| Kidney | 1 | 2019 | 528 | 0.110 |
Why?
|
| Drainage | 1 | 2015 | 66 | 0.110 |
Why?
|
| Femoral Artery | 2 | 2016 | 50 | 0.110 |
Why?
|
| Proportional Hazards Models | 1 | 2017 | 804 | 0.110 |
Why?
|
| Radiation Effects | 2 | 2012 | 4 | 0.110 |
Why?
|
| Disease Progression | 1 | 2017 | 634 | 0.110 |
Why?
|
| Emergency Medical Services | 1 | 2017 | 189 | 0.110 |
Why?
|
| Pulsatile Flow | 2 | 2012 | 25 | 0.110 |
Why?
|
| Lactic Acid | 2 | 2018 | 59 | 0.110 |
Why?
|
| Bioreactors | 2 | 2012 | 61 | 0.110 |
Why?
|
| Sheep | 2 | 2012 | 233 | 0.100 |
Why?
|
| Hemofiltration | 1 | 2013 | 3 | 0.100 |
Why?
|
| Multiple Organ Failure | 1 | 2013 | 11 | 0.100 |
Why?
|
| California | 1 | 2013 | 68 | 0.100 |
Why?
|
| Renal Replacement Therapy | 1 | 2013 | 18 | 0.100 |
Why?
|
| Sensitivity and Specificity | 1 | 2015 | 614 | 0.100 |
Why?
|
| Respiratory Distress Syndrome, Adult | 1 | 2013 | 51 | 0.100 |
Why?
|
| Costs and Cost Analysis | 1 | 2013 | 113 | 0.100 |
Why?
|
| Acute Disease | 1 | 2013 | 277 | 0.090 |
Why?
|
| Jugular Veins | 1 | 2012 | 27 | 0.090 |
Why?
|
| Cells, Cultured | 2 | 2012 | 889 | 0.090 |
Why?
|
| Carotid Arteries | 1 | 2012 | 116 | 0.090 |
Why?
|
| Arteriovenous Shunt, Surgical | 1 | 2012 | 48 | 0.090 |
Why?
|
| Socioeconomic Factors | 1 | 2013 | 447 | 0.090 |
Why?
|
| Dogs | 1 | 2012 | 130 | 0.090 |
Why?
|
| Regional Medical Programs | 1 | 2011 | 4 | 0.090 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2011 | 22 | 0.090 |
Why?
|
| Cholagogues and Choleretics | 1 | 2011 | 3 | 0.090 |
Why?
|
| Technetium Tc 99m Lidofenin | 1 | 2011 | 3 | 0.090 |
Why?
|
| Ursodeoxycholic Acid | 1 | 2011 | 4 | 0.090 |
Why?
|
| Cholangiopancreatography, Magnetic Resonance | 1 | 2011 | 8 | 0.090 |
Why?
|
| False Negative Reactions | 1 | 2011 | 22 | 0.080 |
Why?
|
| Tissue Scaffolds | 2 | 2012 | 435 | 0.080 |
Why?
|
| Ceftriaxone | 1 | 2011 | 15 | 0.080 |
Why?
|
| Pancreatitis | 1 | 2011 | 20 | 0.080 |
Why?
|
| Pneumonia, Bacterial | 1 | 2011 | 37 | 0.080 |
Why?
|
| Actins | 1 | 2011 | 56 | 0.080 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2011 | 40 | 0.080 |
Why?
|
| Radiography, Interventional | 1 | 2011 | 34 | 0.080 |
Why?
|
| Adult | 6 | 2020 | 10048 | 0.080 |
Why?
|
| Vasoconstriction | 1 | 2011 | 46 | 0.080 |
Why?
|
| Age of Onset | 1 | 2011 | 95 | 0.080 |
Why?
|
| Carotid Artery, Common | 1 | 2011 | 49 | 0.080 |
Why?
|
| Chi-Square Distribution | 1 | 2011 | 305 | 0.080 |
Why?
|
| Coculture Techniques | 1 | 2011 | 87 | 0.080 |
Why?
|
| Pilot Projects | 3 | 2020 | 586 | 0.080 |
Why?
|
| Bacteria | 1 | 2011 | 56 | 0.080 |
Why?
|
| Cross Infection | 1 | 2011 | 62 | 0.080 |
Why?
|
| Transplantation, Homologous | 1 | 2011 | 165 | 0.080 |
Why?
|
| Vasoconstrictor Agents | 1 | 2011 | 65 | 0.080 |
Why?
|
| Myosin Heavy Chains | 1 | 2011 | 89 | 0.080 |
Why?
|
| Analysis of Variance | 1 | 2011 | 508 | 0.080 |
Why?
|
| Cohort Studies | 2 | 2011 | 1910 | 0.080 |
Why?
|
| Hospitalization | 2 | 2011 | 500 | 0.080 |
Why?
|
| Breast Neoplasms | 1 | 2016 | 806 | 0.080 |
Why?
|
| Aged | 6 | 2016 | 11023 | 0.080 |
Why?
|
| Renal Dialysis | 1 | 2012 | 282 | 0.080 |
Why?
|
| Young Adult | 3 | 2016 | 2837 | 0.080 |
Why?
|
| Trauma Severity Indices | 2 | 2020 | 50 | 0.080 |
Why?
|
| Combined Modality Therapy | 1 | 2011 | 590 | 0.070 |
Why?
|
| Fluid Therapy | 1 | 2009 | 25 | 0.070 |
Why?
|
| Hydropneumothorax | 1 | 2009 | 3 | 0.070 |
Why?
|
| Rupture, Spontaneous | 1 | 2009 | 21 | 0.070 |
Why?
|
| Logistic Models | 1 | 2011 | 808 | 0.070 |
Why?
|
| Comorbidity | 1 | 2011 | 596 | 0.070 |
Why?
|
| Electrocoagulation | 1 | 2009 | 12 | 0.070 |
Why?
|
| Guideline Adherence | 1 | 2010 | 122 | 0.070 |
Why?
|
| Middle Aged | 6 | 2016 | 12735 | 0.070 |
Why?
|
| Laryngoscopy | 1 | 2009 | 41 | 0.070 |
Why?
|
| Urine | 1 | 2009 | 70 | 0.070 |
Why?
|
| Salvage Therapy | 1 | 2009 | 138 | 0.070 |
Why?
|
| Anti-Bacterial Agents | 1 | 2011 | 352 | 0.070 |
Why?
|
| Sus scrofa | 2 | 2020 | 49 | 0.070 |
Why?
|
| Ischemia | 2 | 2019 | 119 | 0.070 |
Why?
|
| Age Factors | 1 | 2011 | 1262 | 0.070 |
Why?
|
| Survival Analysis | 2 | 2020 | 510 | 0.060 |
Why?
|
| Risk Factors | 1 | 2015 | 4137 | 0.060 |
Why?
|
| Survival Rate | 2 | 2017 | 928 | 0.050 |
Why?
|
| North Carolina | 3 | 2014 | 1621 | 0.050 |
Why?
|
| Patient Selection | 2 | 2016 | 291 | 0.040 |
Why?
|
| Water-Electrolyte Balance | 1 | 2020 | 17 | 0.040 |
Why?
|
| Acidosis | 1 | 2020 | 18 | 0.040 |
Why?
|
| Hypocalcemia | 1 | 2020 | 14 | 0.040 |
Why?
|
| Hyperkalemia | 1 | 2020 | 16 | 0.040 |
Why?
|
| Hypoglycemia | 1 | 2020 | 45 | 0.040 |
Why?
|
| Aircraft | 1 | 2020 | 6 | 0.040 |
Why?
|
| Aldosterone | 1 | 2019 | 27 | 0.040 |
Why?
|
| Automation | 1 | 2019 | 30 | 0.040 |
Why?
|
| Perfusion | 1 | 2019 | 78 | 0.040 |
Why?
|
| Statistics, Nonparametric | 1 | 2019 | 138 | 0.040 |
Why?
|
| Hydrocortisone | 1 | 2019 | 61 | 0.040 |
Why?
|
| Creatine Kinase | 1 | 2018 | 11 | 0.040 |
Why?
|
| Myoglobin | 1 | 2018 | 11 | 0.040 |
Why?
|
| Homeostasis | 1 | 2019 | 137 | 0.040 |
Why?
|
| Hypothermia | 1 | 2018 | 12 | 0.040 |
Why?
|
| Renin | 1 | 2019 | 109 | 0.040 |
Why?
|
| Hindlimb | 1 | 2018 | 55 | 0.030 |
Why?
|
| Muscles | 1 | 2018 | 69 | 0.030 |
Why?
|
| Angiotensin II | 1 | 2019 | 244 | 0.030 |
Why?
|
| Ventricular Function, Left | 1 | 2019 | 287 | 0.030 |
Why?
|
| Blood Flow Velocity | 1 | 2017 | 87 | 0.030 |
Why?
|
| Angiography | 1 | 2017 | 79 | 0.030 |
Why?
|
| Breast Diseases | 1 | 2016 | 4 | 0.030 |
Why?
|
| Aneurysm, False | 1 | 2016 | 15 | 0.030 |
Why?
|
| Anastomosis, Surgical | 1 | 2016 | 60 | 0.030 |
Why?
|
| Monitoring, Physiologic | 1 | 2017 | 84 | 0.030 |
Why?
|
| Equipment Design | 1 | 2016 | 192 | 0.030 |
Why?
|
| International Classification of Diseases | 1 | 2014 | 22 | 0.030 |
Why?
|
| Ultrasonography, Doppler, Pulsed | 1 | 2012 | 6 | 0.020 |
Why?
|
| Angiography, Digital Subtraction | 1 | 2012 | 19 | 0.020 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2012 | 19 | 0.020 |
Why?
|
| Equipment Failure Analysis | 1 | 2012 | 47 | 0.020 |
Why?
|
| Graft Occlusion, Vascular | 1 | 2012 | 25 | 0.020 |
Why?
|
| Punctures | 1 | 2012 | 35 | 0.020 |
Why?
|
| Constriction, Pathologic | 1 | 2012 | 47 | 0.020 |
Why?
|
| Needles | 1 | 2012 | 33 | 0.020 |
Why?
|
| Regional Blood Flow | 1 | 2012 | 95 | 0.020 |
Why?
|
| Stress, Mechanical | 1 | 2012 | 102 | 0.020 |
Why?
|
| Materials Testing | 1 | 2012 | 93 | 0.020 |
Why?
|
| Prosthesis Failure | 1 | 2012 | 58 | 0.020 |
Why?
|
| Models, Animal | 1 | 2012 | 198 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2012 | 177 | 0.020 |
Why?
|
| Stem Cell Transplantation | 1 | 2012 | 229 | 0.020 |
Why?
|
| Algorithms | 1 | 2012 | 561 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2010 | 431 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2010 | 922 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2011 | 4157 | 0.010 |
Why?
|